Safety and Efficacy of Programmed Cell Death 1 and Programmed Death Ligand-1 Inhibitors in the Treatment of Cancer: An Overview of Systematic Reviews

Overview of attention for article published in Frontiers in immunology, July 2022

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (60th percentile)
Good Attention Score compared to outputs of the same age and source (69th percentile)

Mentioned by

twitter: 7 X users

Citations

dimensions_citation: 16 Dimensions

Readers on

mendeley: 18 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 7 X posts from 7 X users, with an upper bound of 46,790 followers.

Safety and Efficacy of Programmed Cell Death 1 and Programmed Death Ligand-1 Inhibitors in the Treatment of Cancer: An Overview of Systematic Reviews https://t.co/ZlRuLtBpco https://t.co/tokzMRpTfD

02 Aug 2022

Reply Repost Favourite

New article: Safety and Efficacy of Programmed Cell Death 1 and Programmed Death Ligand-1 Inhibitors in the Treatment of Cancer: An Overview of Systematic Reviews https://t.co/5qrBaqbbqZ #lungcancer #oncology https://t.co/oSC8BFe85A

01 Aug 2022

Reply Repost Favourite

RT @FrontImmunol: New Research: Safety and Efficacy of Programmed Cell Death 1 and Programmed Death Ligand-1 Inhibitors in the Treatment of…

13 Jul 2022

Reply Repost Favourite

RT @FrontImmunol: New Research: Safety and Efficacy of Programmed Cell Death 1 and Programmed Death Ligand-1 Inhibitors in the Treatment of…

13 Jul 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 3 additional X posts.